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A human teratoma call line (Tcra 3) was grown in serum-free medium, and the population multiplication was stimulated by the addition of I-10 
ng basic fibroblast growth factor (bFGF)/ml. The bFGF-effect was abrogated by the addition of protamin sulphate. When high concentrations 
of bFCiF were added, apreferential effect on cell locomotion was observed. 100 ng bFGF/ml stimulated cell movement but only exerted amarginal 
effect on cell multiplication. These observed exogenous requirements for multiplication and locomotion werti complemented by the expression of 
bFGF receptors. Seatchard analysis of binding datu suggests the cxisiencc of a high-aflinity and a low-affinity class of receptors, 
Fibroblast growth factor; Cell multiplication; Cell motility 
1. INTRODUCTION mRNA for these species has been described recently 
[101* 
The acidic and basic fibroblast growth factors were 
the first members of a class of highly mitogenic peptides 
with a strong affinity for heparin to be isolated. Since 
their discovery, six members of the larger family have 
been isolated and characterised from a wide variety of 
sources and exhibit pleiotropic effects on a broad range 
of mainly mesoderm- and neurectoderm-derived cell 
types [I ,2]. They stimulate cell proliferation, migration 
and differentiation at a range of concentrations with 
maximal effects between 0.1 and 1 ng/ml, and almost 
uniquely show qualitative modulation of their biologi- 
cal functions with c1~at-r~:: i:; concentration. For exam- 
ple in the eye, bFGF stimulates proliferation of lens 
epithelial cells at low concentrations but induces cell 
migration at higher doses [3]. 
The range of properties hown by the FGF family 
suggests that these might be important molecules in the 
processes of embryogenesis. The factors may modulate 
the rate of expansion of stem cell populations by affect- 
ing both differentiation (for example induction of col- 
lagen synthesis in chondrocytes [4], and differentiation 
of preadipocyte fibroblasts in to adipocytes [S]) and 
proliferation, e.g. by repressing the terminal differentia- 
tion of myoblasts into myotubes [6]. Additionally, they 
have been implicated as potential mediators of mor- 
phogenetic information in amphibian development [7,8] 
and as important factors in the modelling of tissues 
during organogenesis [9]. The embryonic distribution of 
Heparin-binding rowth factors are reported to be 
synthesized in the ovary and testis [11,12], messenger 
RNAs are expressed in and proteins have been isolated 
from proliferating and differentiated populations of 
mouse and human teratocarcinoma cells (reviewed in 
[13]). In one instance it is known that the FGF-related 
molecules (ECDGF) are able to participate in a pa- 
racrine growth loop by stimulating the proliferation of 
the differentiated erivatives of the EC population [143, 
and it has been speculated that parietal endoderm of the 
mouse embryo may have a similar role. As these 
processes may reflect a normal interaction during em- 
bryogenesis, it is intriguing that such loops may con- 
tinue to operate in tumour tissue. This suggests that 
continued inappropriate paracrine growth stimulation 
may contribute to the proliferation of the tumour tissue, 
influence the various differentiation pathways een in 
teratocarcinoma [15], or due to the potent angiogenic 
properties of the FGFs, stimulate tumour invasion by 
capillaries. 
Corrcsportrlew rrdrlr~~s~ W. Engstri5m, Center for Biotechnology, Ka- 
rolinska Institutet, NOVUM, ?~I41 52, Huddinge, Sweden. 
We have previously shown that undifferentiated 
populations of the cloned human teratocarcinoma cell 
line Tera-2 synthesise messenger RNA for basic fibro- 
blast growth factor and K-FGF [ 151, but it has not been 
possible to purify these peptides from conditioned 
medium. This problem was also reported for several 
mouse teratocarcinoma cell lines [IG]. We report here 
that Tera-2 will proliferate in serum-free medium in the 
so!e presence of recombi..,.. nq**t basic FGF. This effect is 
accompanied by changes in cell shape and motility. The 
effects are mediated through classical FGF receptors, 
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are sensitive to protamine sulphate, and demonstrate a
qualitative dependance on concentration. 
2. MATERIALS AND METHODS 
2, I I Cd cuhuw 
Tera-2 cells were routinely passaged as described by Thompson et 
al. [I71 in alpha modified Eagles’ medium and 10% heat-inactivated 
fetal bovine serum (ScraLab). ScrumJree medium was essentially as 
described by Biddle et al. [18] beingcomposed ofa I:1 mixturcofalpha 
modilied Eagles medium (lacking nuclcosides and deoxyribonu- 
cleosidcs) and Hams’ F12 medium (Gibco, UK), supplemented with 
10 &ml human transl’crrin prcloaded with iron in accordance with 
the manufacturers instructions. 
Two days prior to an experiment, cultures were weaned onto alpha/ 
Ham supplemented with IO% fetal calf serum, to allow the cells to 
adapt o the basal medium used in lhc serum-freeculture experiments. 
Cells were harvested by rinsing in PBS (solution A [19]) and then 
briefly exposed to trypsin vcrsene, and chick plasma, Cells were taken 
up in 10% FCS, collected by centrifugation and counted in a haemo- 
cyiomcter. 
All subsequent procedures were carried out as described in Biddle 
et al. [IS]. Cells for growth curves were plated out at a density of I .4-3 
x IO5 cells in each 6-cm diameter Primaria dish (Beckton-Dickinson. 
UK) and allowed to attach overnight in 10% FCS/alpha/Ham. Cul- 
tures were then exlensively washed and medium with FCS replaced 
with serum&ee medium. The following day cells were counted, and 
this was taken as the starting point ofthcexperimcnt. Countingofcells 
exposed to cxperimcntal conditions was carried out al’ler exposure of 
wushcd monolayers to trypsin/EDTA for 20 min at room temperature 
to ensure complete harvesting. The range ofcell counts in thcduplicatc 
and triplicate dishes rarely exceeded 10% of the mean cell count. 
The results of several of these studies were expressed as the number 
of population doublings that had occurred since the start of the exper- 
iment. This method eliminates day to day variation in the rate of 
population increase and was a single point assay, detailed in Biddle 
et al, [IS]. 
2.2. Gro~rl~ ficrors 
The additives used included human basic fibroblasl growth factor 
(R&D via British Biotechnology, Oxford) and insulin-like growth 
factor-l (Amersham, UK). Protamine sulphatc was purchased from 
Sigma, Poole, UK. 
2.3. Ciorrul o~~u/_i~ssis of ce l tttuiriplicutiot~ srttd cc4 locottzoriott 
The cells were plated at differeni densities ranging from 10-100 cells 
per cm? inlo equilibrated medium in the 35.mm wells of six-cluster 
dishes. After 5 days, each culture was fixed in 3: I methanol/acetic a id 
for at least 24 h, hydrated in Analar water. and tinally stained with 
Crystal violet. Each dish was examined under a Leitz inverted micro- 
scope quipped with an eyepiece graticule inscribed with lOconcentric 
circles. The distance between two circles was taken as one relative unit. 
Image analysis using a C-Scan (Cambridge) analyser allowed for 
qunntitation of colony size in parallel and gave identical results to the 
manual method. 
Each dish was scanned in the microscope and the location ofcach 
colony was marked. The diameter of each colony was determined by 
use of the graticulc, whereafter the number of cells in each colony was 
counted. In several instances lhe colonies were photographed under 
a Leitz inverted microscope with an attached camera system. 
Radioiodinated FGF was prepared according to Ncufeld and Gas 
podarowicn [20] and purified by hcparin Sepharose affinity chromat- 
ography. Specific activities of4-8 x IO’ cpm/ng were obtained in this 
way. 
Tera-2 cells were plated out on geluliniscd 24-well cluster plates at 
2 x IO5 cells per well in alpha MEMIIOB FCS and allowed to attach 
and grow overnight. Plates were transferred to ice, medium aspirated 
and cells washed 5x with 500 yl phosphate-buffered saline. Subse- 
quently 200 ,ul of hinding bulTcr (alpha MEM + 25 mM HEPES + 
0.2% gelatin) were added to each we11 together with increasing con- 
centralions oflabelled FGF (0.01-10 ndml). Non-specific bindin8was 
estimated by including 2ydml unlabelled FGF with duplicatesamples 
to which had been added 0.5 ng of iodinated bFGF/ml and binding 
to dishes by adding 5 ng of iodinated bFGF/ml to dishes without cells 
in 200 yl of binding buffer. Plates were incubated at 4°C for 4 h, 
medium aspirated and cells washed with 0.5 ml PBS/O.I% BSA three 
times. Membranes were then solubilised with 400~1 of Triton X-100 
+ 0.1% BSA and counted in an LKB rack gamma counter. Greater 
than 95% of counts bound to cells on incubation with 0.5 n&/ml of 
iodinated FGF could be displaced by 2pdrnl ofunlabelled competitor 
in repeat data sets. This was taken as a measure of non-specific binding 
and subtracted from the binding data. This data was sub’squently 
converted to the Scatchard [21] form and analyses using the 
programmc LIGAND, All figures were corrected for non-speeifrc 
binding as described above 
2.5. FGF wcqtor cross-linking 
Receptor cross-linking was carried out essentially according to 
Neufeld and Gospodato&s 1221.  x lo6 Tera-2 cells were plated out 
onto gelatin&d 600.mm dishes andallowed toattach overnight. Rind- 
ing was carried out at 4°C in I.2 ml of the binding buffer of Neufcld 
and Gospodarowicz [?O]. 100 @ml of iodinated FGF was added to 
each dish. Competitor was added at 2 pg&nl to one set of dishes and 
increasing concentrations of protamine sulphate (I.5 and IOyg/ml) to 
the remaining dishes. Dishes were incubated for 2.5 h on a rotating 
platform at 2 cycles per second, washed in IO ml of PBS and cross- 
linked at room remperaturc with 20 mM disuccinimidyl suberate 
(Aldrich) in 2 ml of PBS. Harvesting of membranes was carried out 
as described in1221 and analyscd on 5% Laemmli SDS-polyacrylamidc 
denaturing els using the Amersham (Amcrsham, UK). Rainbow 
markers for calibration. 
3. RESULTS 
3.1. Growth effects 
Daily addition of recombinant FGF to Tera-2 cells 
plated out in serum-free medium over a Cday period 
showed that proliferation of the cells could be 
supported by 20 ng/ml FGF as the sole macromolecular 
additive, resulting in a 1.3-fold doubling in population 
over the time course of the experiment as compared 
with controls which showed essentially no growth. The 
proliferative response increases with increasing con- 
centrations of bFGF and reaches a maximum at 20 
ng/ml (Fig. 1). No further stimulatory effect could be 
achieved by adding higher doses of the growth factor. 
The effects of bFGF are inhibitable by low concentra- 
tions (lOpg/ml) of protamine sulphate (data not shown) 
as previously reported by Gospodarowicz et al. [23] and 
inclusion of this agent in growth experiments substan- 
tially reduced the biological effects of the bFGF 
suggesting that the molecule is acting through similar 
receptors to those previously characterised. 
3.2. Cell migration 
To study the relationship between cell multiplication 
and cell locomotion we seeded Tera-2 cells at clonal 
density and grew them with the addition of 10 ng/ml of 
basic FGF. In this set of experiments he number ofcells 
1% 
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Fig. 1. Dosedependent s imulation of Tera-2 cell proliferation by 
basic FGF. Cells were plated out at a nominal density of I x 10’ cells 
per 600-mm dish, washed after 24 h and medium replaced with alpha/ 
Ham alone or supplemented with basic FGF at 5-200 ns;ml, After 4 
days replicate dishes were counted in triplicate and figures related to 
appropriate controls. 
as well as the diameter was scored for each colony. In 
order to exclude the possibility that any observed effects 
on cell migration were a consequence of an increased 
rate of cell proliferation, the diameters of colonies that 
consisted of equal numbers of cells were examined in the 
presence and absence of bFGF. 
It was shown that bFGF stimulates clonal cell pro- 
liferation as determined by cells/colony in a concentra- 
tion-dependent manner. The maximum increase in cell 
numbers was observed at 10 @ml. Increasing the con- 
centration over and above this slightly decreased cell 
numbers. Fig. 2A-C demonstrates that irrespective of 
colony size, as defined by numbers of cells per colony, 
only high doses of bFGF (100 @ml) significantly in- 
creased the colony diameter. In contrast, lower con- 
centrations of bFGF (l-10 rig/ml) did not significantly 
increase the colony diameter. The stimulatory effect on 
cell locomotion was ascribable to bFGF since it could 
be completely abrogated by simultaneous addition of 
protamine sulphate (data not shown). 
3.3. SF receptors 
It is important in this type of analysis to establish that 
the observed requirements are complemented by expres- 
sion of the appropriate growth factor receptors. Fig. 3 
shows the results of FGF binding experiments on Tcra- 
2 cells. Scatchard analysis of the binding data yields a 
total number of 22,500 and 200,000 sites per cell made 
up of two populations of sites with high- and low-affin- 
ity dissociation constants of 16.7 pM and 51 nM, the 
former accounting for approximately 22,500 sites per 
6 6 6 
0 . . . . . . . . . . . . . . . . . . ..0....................10 ,',,,',,,,,,,,,,,4'1 
6-10 II-15 16-20 6.10 1145 16-20 6.10 11.15 16-20 
Celle/Colony 
Fig. 2, The erect of SFGF on c!onel 1ocomc:ion of ‘5~2-2 cells. Cells vverc seeded onto 3%mm dishes 21 2 concentration of 20 cells/cm’ in IQ 
serum. The media were either supplemented with 1 (A), IO (B), or IO0 (C) ng bFGF per ml (@), or nothing (B). After 5 days the disks were fixed 
and the diameter and the cell number of each colony determined under a light microscope. The mean diameters were calculated on colonies with 
comparable cell numbers. For this purpose the colonies were pooled into clusters that ranged over 5 cell numbers (abscissa), e.g. 6-10, I I-I 5, 16-20 
etc. as described in [30]. The curves represent means P SD. from three different experiments. 
156 
Volu~nc 298, number 2,3 
Uinding UP bFCP to monulaycre 
FEBS LElTERS February 1992 
0.434 
% 
$ 0.217 
ll 
bPGF lfuund (PM) 
Fig. 3. Binding of [1z91]bFGF tomonolayers of Tcra-2 cells was carried 
out as described in section 2. In this experiment the specific activity 
of bFGF used was 1 x lo3 dpm/pmol. Saturation binding data col- 
lected in triplicate were analysed using the programme EEDA 
(BioSoft) and the resultant estimates of K,, and saturation binding 
analyscd using the iterative curve fitting programme LIGAND. The 
data were best fitted to a model with two non-cooperative classes of 
binding site (P e 0.05). The highest affinity sites having a Kd of 16.7 
pM (22,500 receptors per cell, and the lowest affinity 5 I nM (200,O-OO 
receptors per cell). 
cell and the latter 200,000. Cross-linking of radioio- 
dinated l&and to monolayers indicated a single species 
of receptor of M, 150 kDa to which ligand binding 
could be competed with an excess of unlabelled ligand 
or increasing concentrations of protamine sulphate 
(Fig. 4). It is particularly important to note that the 
degree of protamine sulphate induced inhibition of 
binding of FGF to its receptor mirrors the dose- 
response relationship for inhibition of FGF stimulated 
growth thus providing good circumstantial evidence 
that the growth effects are mediated through the 150 
kDa receptor. 
4. DISCUSSION 
Synthesis of heparin binding growth factors has been 
reported by several authors previously, for example 
NTera-2 a derivative of Tera-2 is known to express 
mRNA for bFGF and to synthesise material immu- 
nologically related to FGF [24], but the response of 
human teratocarcinoma cells to such factors has not 
previously been characterised. Although mRNA for 
bFGF has been detected in Tera-2 cells attempts to 
purify it from conditioned media have so far failed; a 
similar problem exists with the purification from mouse 
teratocarcinoma cells which also contain transcripts. 
This results in the potential autocririe or paracrine loop 
available for Tera-2 cell growth not being completed for 
basic FGF. This paradoxical finding that cells express- 
ing bFGF also require it for their growth is frequent for 
FCF dependent cclfs, such as capi!!ary endothe!ia! ce!!s 
and emphasises the problems associated with lack of 
secretion of FGF. However, it must be considered that 
bFGF is not the ligand to which cells are reacting in 
l?Kd- 
Fig. 4. Cross-linking of [lzSl]bFGF to Tera-2 ccl1 membranes. 100 
ndml [‘“51]bFGF was incubated with monolayers of Ten-2 cells, at 
4OC as described in section 2. competitor (unlabelled bFGF) was 
added at I ngml, 100 q/ml and 2p@nl to one set of dishes and to 
a set of dishes containing radiolabelled l&and alone. increasing con- 
centrations of protamine sulphate (Prot, S) (1,s and IO,udml). Ligand 
and receptors cross-linked at room temperature with 20 mM disucci- 
nimidyl suberatc (Aldrich) in 2 ml of PBS. Harvesting of membranes 
was carried out as described in section 2 and analyscd on 5% Laemmli 
polyacrylamide-SDS denaturing els using the Amersham (Amenham 
PLC, UK) Rainbow markers for calibration. 
vivo. Just as the EGF receptor eacts equally well with 
TGFa, which is probably the most abundant phys- 
iological ligand, it is plausible that the different FGF 
receptors may also interact with different members of 
the FGF family [20,25-271. 
Tera-2 possesses one size class of single chain high- 
affinity cross linkable receptor with an M, of approxi- 
mately 150 kDa. Scatchard analysis of binding data 
indicates two types of binding site, one high-affinity site 
with a K,, of 16.7 pM and 22,500 receptors per cell and 
a low-affinity site. A wide range of receptor numbers 
and affinities has been reported for different cells with 
K,, values ranging from 11 pM to 270 pM and numbers 
of receptors per cell from 0.2 x 1 O5 to 1 x 105. Moreover, 
four distinct FGF-receptor genes have hitherto been 
cloned and sequenced [25-271. 
In this Tera-2 shows a typical number of receptors 
with high affinity. Molecular weights have been 
reported between 110 and 165 kDa with most cells hav- 
ing at least two cell surface species resolvable by electro- 
phoresis of ligand cross-linked receptor. The class of 
157 
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low-affinity binding sites with a K of 51 nM is rather 
higher than the estimated binding of bFGF to extracel- 
lulnr matrix but it is not unrealistic to suggest hat this 
class of binding site is indeed on the matrix as a large 
number of sites are present, equivalent o 200,000 per 
cell. Both the biological effects of bFGF are inhibited 
by protamine sulphate, and the concordance between 
dose/inhibition data for biological effect and binding to 
the receptor in cross-linking experiments upports the 
previous findings of Gospodarowicz et al. [9] and allows 
discrimination between two potential mechanisms of 
action of insulin-like growth factors, direct or via 
bFGF. Moreover, others have reported effects of FGF 
on migration of several cell types including fibroblasts 
and endotheliai cells [Z&303. The concentration-de- 
pendent difference in biological effect is clearly demon- 
strated in studies with lens epithelial cells, and reflects 
the finding here that high concentrations of bFGF 
affect cell migration. It is tempting to speculate that the 
low-affinity sites either on the cells or more probably in 
the ECM are responsible for inducing this response (e.g. 
P3lJ 
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